Global Spine Biologics Industry 2016 Market Research Report

Market: Pharma & Healthcare

, 172 pages report, published by QYResearch

Report ThumbnailJuly-2016
The Global Spine Biologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the spine biologics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The spine biologics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The spine biologics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 276 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

  • List of Tables and Figures
  • Figure Picture of Spine Biologics 1
  • Table Comparison of Main Models from Spine Biologics Major Manufacturers 2
  • Table Specification of Main Models from Spine Biologics Major Brand 2
  • Table Specification Comparison of Different Types of Spine Biologics 3
  • Figure Global Production Market Share of Spine Biologics by Type in 2015 3
  • Figure Bone Graft Picture 4
  • Figure Bone Graft Substitute Picture 4
  • Figure Platelet Rich Plasma Picture 5
  • Figure BMAC Picture 5
  • Table Applications of Spine Biologics 6
  • Figure 2015 Global Spine Biologics Major Applications Sales Share 6
  • Figure Anterior Cervical Discectomy and Fusion Examples 7
  • Figure Posterior Lumbar Interbody Fusion Examples 7
  • Figure Industry Chain Structure of Spine Biologics 8
  • Table Global Spine Biologics Major Manufacturers 9
  • Table Global Major Regions Spine Biologics Production Market Share in 2015 9
  • Table Industry Policy of Spine Biologics 10
  • Table Industry News List of Spine Biologics 12
  • Table Raw Material Suppliers Analysis 15
  • Table Equipment Suppliers Analysis 16
  • Figure 2014 APAC Overview of Average Monthly Labor Cost 17
  • Figure 2014 Americas Overview of Average Monthly Labor Cost 17
  • Figure 2014 EMEA Overview of Average Monthly Labor Cost 18
  • Figure 2010-2015 USA Employment Cost Index (ECI) 18
  • Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNY/a) 19
  • Table 2015 Electricity Price of Industry (USD/KW·h) by Some Country 19
  • Table Manufacturing Cost Structure Analysis of Spine Biologics in 2015 20
  • Figure Manufacturing Process Analysis of Spine Biologics 21
  • Table Capacity (K Units) of Global Spine Biologics Key Manufacturers in 2015 22
  • Table Key Manufacturing Plants Distribution of Global Spine Biologics Major Manufacturers in 2015 22
  • Table R&D Status and Technology Source of Global Spine Biologics Key Manufacturers in 2015 23
  • Table Global Capacity (K Units) of Spine Biologics by Regions 2011-2016 24
  • Figure Global Capacity Market Share of Spine Biologics by Regions in 2011 24
  • Figure Global Capacity Market Share of Spine Biologics by Regions in 2015 25
  • Table Global Production (K Units) of Spine Biologics by Regions 2011-2016 25
  • Figure Global Production Market Share of Spine Biologics by Regions in 2011 25
  • Figure Global Production Market Share of Spine Biologics by Regions in 2015 26
  • Table Global Revenue (M USD) of Spine Biologics by Regions 2011-2016 26
  • Figure Global Revenue Market Share of Spine Biologics by Regions in 2011 26
  • Figure Global Revenue Market Share of Spine Biologics by Regions in 2015 27
  • Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 27
  • Figure Global Capacity Utilization Rate of Spine Biologics 2011-2016 28
  • Figure Global Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 28
  • Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 29
  • Figure North America Capacity Utilization Rate of Spine Biologics 2011-2016 29
  • Figure North America Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 30
  • Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 30
  • Figure Europe Capacity Utilization Rate of Spine Biologics 2011-2016 31
  • Figure Europe Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 31
  • Figure Asia Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 32
  • Figure Asia Capacity Utilization Rate of Spine Biologics 2011-2016 32
  • Figure Asia Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 33
  • Table Global Production (K Units) of Spine Biologics by Types 2011-2016 33
  • Figure Global Production Market Share of Spine Biologics by Types in 2011 34
  • Figure Global Production Market Share of Spine Biologics by Types in 2015 34
  • Table Global Revenue (M USD) of Spine Biologics by Types 2011-2016 35
  • Figure Global Revenue Market Share of Spine Biologics by Types in 2011 35
  • Figure Global Revenue Market Share of Spine Biologics by Types in 2015 36
  • Table Global and Major Manufacturers Capacity (K Units) of Spine Biologics 2011-2016 36
  • Table Global Capacity Market Share of Spine Biologics Major Manufacturers 2011-2016 37
  • Figure Global Capacity Market Share of Spine Biologics Major Manufacturers in 2011 37
  • Figure Global Capacity Market Share of Spine Biologics Major Manufacturers in 2015 38
  • Table Global and Major Manufacturers Production (K Units) of Spine Biologics 2011-2016 38
  • Table Global Production Market Share of Spine Biologics Major Manufacturers 2011-2016 39
  • Figure Global Production Market Share of Spine Biologics Major Manufacturers in 2011 39
  • Figure Global Production Market Share of Spine Biologics Major Manufacturers in 2015 40
  • Table Global and Major Manufacturers Revenue (M USD) of Spine Biologics 2011-2016 40
  • Table Global Revenue Market Share of Spine Biologics Major Manufacturers 2011-2016 41
  • Figure Global Revenue Market Share of Spine Biologics Major Manufacturers in 2011 41
  • Figure Global Revenue Market Share of Spine Biologics Major Manufacturers in 2015 42
  • Table Price (USD/Unit) of Spine Biologics by Regions 2011-2016 43
  • Figure Price (USD/Unit) of Spine Biologics by Regions in 2015 43
  • Table Cost (USD/Unit) of Spine Biologics by Regions 2011-2016 44
  • Figure Cost (USD/Unit) of Spine Biologics by Regions in 2015 44
  • Table Gross (USD/Unit) of Spine Biologics by Regions 2011-2016 44
  • Figure Gross (USD/Unit) of Spine Biologics by Regions in 2015 45
  • Table Gross Margin of Spine Biologics by Regions 2011-2016 45
  • Figure Gross Margin of Spine Biologics by Regions in 2015 45
  • Table Price (USD/Unit) of Spine Biologics by Types 2011-2016 46
  • Figure Price (USD/Unit) of Spine Biologics by Types in 2015 46
  • Table Cost (USD/Unit) of Spine Biologics by Types 2011-2016 46
  • Figure Cost (USD/Unit) of Spine Biologics by Types in 2015 47
  • Table Gross (USD/Unit) of Spine Biologics by Types 2011-2016 47
  • Figure Gross (USD/Unit) of Spine Biologics by Types in 2015 48
  • Table Gross Margin of Spine Biologics by Types 2011-2016 48
  • Figure Gross Margin of Spine Biologics by Types in 2015 49
  • Table Price (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 49
  • Figure Price (USD/Unit) of Spine Biologics by Manufacturers in 2015 50
  • Table Cost (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 50
  • Figure Cost (USD/Unit) of Spine Biologics by Manufacturers in 2015 51
  • Table Gross (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 51
  • Figure Gross (USD/Unit) of Spine Biologics by Manufacturers in 2015 52
  • Table Gross Margin of Spine Biologics by Manufacturers 2011-2016 52
  • Figure Gross Margin of Spine Biologics by Manufacturers in 2015 53
  • Table Global Consumption Volume (K Units) of Spine Biologics by Regions 2011-2016 54
  • Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2011 55
  • Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2015 55
  • Table Global Consumption Value (M USD) of Spine Biologics by Regions 2011-2016 56
  • Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2011 56
  • Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2015 57
  • Figure Global Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 57
  • Figure Global Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 58
  • Figure North America Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 58
  • Figure North America Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 59
  • Figure Europe Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 59
  • Figure Europe Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 60
  • Figure China Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 60
  • Figure China Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 61
  • Figure Asia (Ex. China) Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 61
  • Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 62
  • Table Global Consumption Volume (K Units) of Spine Biologics by Types 2011-2016 62
  • Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2011 63
  • Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2015 63
  • Table Global Consumption Value (M USD) of Spine Biologics by Types 2011-2016 64
  • Figure Global Consumption Value Market Share of Spine Biologics by Types in 2011 64
  • Figure Global Consumption Value Market Share of Spine Biologics by Types in 2015 65
  • Table Global Consumption Volume (K Units) of Spine Biologics by Applications 2011-2016 65
  • Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2011 66
  • Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2015 66
  • Table Global Consumption Value (M USD) of Spine Biologics by Applications 2011-2016 67
  • Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2011 67
  • Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2015 68
  • Table Sale Price (USD/Unit) of Spine Biologics by Regions 2011-2016 68
  • Table Sale Price (USD/Unit) of Spine Biologics by Types 2011-2016 68
  • Table Sale Price (USD/Unit) of Spine Biologics by Applications 2011-2016 69
  • Table Global Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70
  • Table North America Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70
  • Table Europe Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70
  • Table Asia Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 71
  • Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 71
  • Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 72
  • Table North America Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 72
  • Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 73
  • Table Europe Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 73
  • Table Asia Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 74
  • Table Asia Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 74
  • Table Medtronic Company Profile 75
  • Figure Spine Biologics Product Picture of Medtronic 76
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Medtronic 2011-2016 76
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Medtronic 2011-2016 77
  • Figure Spine Biologics Production (K Units) and Global Market Share of Medtronic 2011-2016 77
  • Table Depuy Synthes Company Profile 78
  • Figure Spine Biologics Product Picture of Depuy Synthes 79
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Depuy Synthes 2011-2016 80
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Depuy Synthes 2011-2016 80
  • Figure Spine Biologics Production (K Units) and Global Market Share of Depuy Synthes 2011-2016 81
  • Table Stryker Corporation Company Profile 81
  • Figure Spine Biologics Product Picture of Stryker Corporation 82
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Stryker Corporation 2011-2016 83
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Stryker Corporation 2011-2016 83
  • Figure Spine Biologics Production (K Units) and Global Market Share of Stryker Corporation 2011-2016 84
  • Table Nuvasive Company Profile 84
  • Figure Spine Biologics Product Picture of Nuvasive 85
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nuvasive 2011-2016 86
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Nuvasive 2011-2016 86
  • Figure Spine Biologics Production (K Units) and Global Market Share of Nuvasive 2011-2016 87
  • Table Zimmer Biomet Company Profile 87
  • Figure Spine Biologics Product Picture of Zimmer Biomet 88
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Zimmer Biomet 2011-2016 89
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Zimmer Biomet 2011-2016 89
  • Figure Spine Biologics Production (K Units) and Global Market Share of Zimmer Biomet 2011-2016 90
  • Table Orthofix International Company Profile 90
  • Figure Spine Biologics Product Picture of Orthofix International 91
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Orthofix International 2011-2016 91
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Orthofix International 2011-2016 92
  • Figure Spine Biologics Production (K Units) and Global Market Share of Orthofix International 2011-2016 92
  • Table Globus Medical Company Profile 93
  • Figure Spine Biologics Product Picture of Globus Medical 94
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Globus Medical 2011-2016 94
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Globus Medical 2011-2016 95
  • Figure Spine Biologics Production (K Units) and Global Market Share of Globus Medical 2011-2016 95
  • Table Alphatec spine Company Profile 96
  • Figure Spine Biologics Product Picture of Alphatec spine 97
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alphatec spine 2011-2016 97
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Alphatec spine 2011-2016 98
  • Figure Spine Biologics Production (K Units) and Global Market Share of Alphatec spine 2011-2016 98
  • Table K2M Company Profile 99
  • Figure Spine Biologics Product Picture of K2M 100
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of K2M 2011-2016 100
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of K2M 2011-2016 101
  • Figure Spine Biologics Production (K Units) and Global Market Share of K2M 2011-2016 101
  • Table Exactech Company Profile 102
  • Figure Spine Biologics Product Picture of Exactech 103
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exactech 2011-2016 103
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Exactech 2011-2016 104
  • Figure Spine Biologics Production (K Units) and Global Market Share of Exactech 2011-2016 104
  • Table Wright Medical Technology Company Profile 105
  • Figure Spine Biologics Product Picture of Wright Medical Technology 106
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Wright Medical Technology 2011-2016 106
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Wright Medical Technology 2011-2016 107
  • Figure Spine Biologics Production (K Units) and Global Market Share of Wright Medical Technology 2011-2016 107
  • Table X-Spine Systems Company Profile 108
  • Figure Spine Biologics Product Picture of X-Spine Systems 109
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of X-Spine Systems 2011-2016 109
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of X-Spine Systems 2011-2016 110
  • Figure Spine Biologics Production (K Units) and Global Market Share of X-Spine Systems 2011-2016 110
  • Table Nutech Company Profile 111
  • Figure Spine Biologics Product Picture of Nutech 112
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nutech 2011-2016 112
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Nutech 2011-2016 113
  • Figure Spine Biologics Production (K Units) and Global Market Share of Nutech 2011-2016 113
  • Table Arthrex Company Profile 114
  • Figure Spine Biologics Product Picture of Arthrex 115
  • Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Arthrex 2011-2016 115
  • Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Arthrex 2011-2016 116
  • Figure Spine Biologics Production (K Units) and Global Market Share of Arthrex 2011-2016 116
  • Figure Marketing Channels of Spine Biologics 117
  • Table Traders or Distributors with Contact Information of Spine Biologics 118
  • Figure Ex-work Price, Channel Price and End Buyer Price of Spine Biologics (USD/Unit) in 2015 119
  • Table Regional Import, Export, and Trade of Spine Biologics (K Units) 119
  • Table Global Capacity (K Units) of Spine Biologics by Regions 2016-2021 121
  • Figure Global Capacity Market Share of Spine Biologics by Regions in 2016 121
  • Figure Global Capacity Market Share of Spine Biologics by Regions in 2021 122
  • Table Global Production (K Units) of Spine Biologics by Regions 2016-2021 122
  • Figure Global Production Market Share of Spine Biologics by Regions in 2016 122
  • Figure Global Production Market Share of Spine Biologics by Regions in 2021 123
  • Table Global Revenue (M USD) of Spine Biologics by Regions 2016-2021 123
  • Figure Global Revenue Market Share of Spine Biologics by Regions in 2016 123
  • Figure Global Revenue Market Share of Spine Biologics by Regions in 2021 124
  • Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 124
  • Figure Global Capacity Utilization Rate of Spine Biologics 2016-2021 124
  • Figure Global Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 124
  • Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 125
  • Figure North America Capacity Utilization Rate of Spine Biologics 2016-2021 125
  • Figure North America Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 126
  • Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 126
  • Figure Europe Capacity Utilization Rate of Spine Biologics 2016-2021 127
  • Figure Europe Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 127
  • Figure Asia Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 128
  • Figure Asia Capacity Utilization Rate of Spine Biologics 2016-2021 128
  • Figure Asia Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 129
  • Table Global Production (K Units) of Spine Biologics by Types 2016-2021 129
  • Figure Global Production Market Share of Spine Biologics by Types in 2016 130
  • Figure Global Production Market Share of Spine Biologics by Types in 2021 130
  • Table Global Revenue (M USD) of Spine Biologics by Types 2016-2021 131
  • Figure Global Revenue Market Share of Spine Biologics by Types in 2016 131
  • Figure Global Revenue Market Share of Spine Biologics by Types in 2021 132
  • Table Global Consumption Volume (K Units) of Spine Biologics by Regions 2016-2021 132
  • Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2016 133
  • Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2021 133
  • Table Global Consumption Value (M USD) of Spine Biologics by Regions 2016-2021 134
  • Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2016 134
  • Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2021 135
  • Figure Global Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 135
  • Figure Global Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 136
  • Figure North America Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 136
  • Figure North America Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 137
  • Figure Europe Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 137
  • Figure Europe Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 138
  • Figure China Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 138
  • Figure China Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 139
  • Figure Asia (Ex. China) Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 139
  • Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 140
  • Table Global Consumption Volume (K Units) of Spine Biologics by Types 2016-2021 140
  • Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2016 141
  • Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2021 141
  • Table Global Consumption Value (M USD) of Spine Biologics by Types 2016-2021 142
  • Figure Global Consumption Value Market Share of Spine Biologics by Types in 2016 142
  • Figure Global Consumption Value Market Share of Spine Biologics by Types in 2021 143
  • Table Global Consumption Volume (K Units) of Spine Biologics by Applications 2016-2021 143
  • Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2016 144
  • Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2021 144
  • Table Global Consumption Value (M USD) of Spine Biologics by Applications 2016-2021 145
  • Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2016 145
  • Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2021 146
  • Table Global Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 146
  • Table North America Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147
  • Table Europe Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147
  • Table Asia Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147
  • Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 147
  • Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 148
  • Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 148
  • Table Asia Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 149
  • Table New Project SWOT Analysis of Spine Biologics 150
  • Table Project Appraisal and Financing 151
  • Table New Project Investment Feasibility Analysis of Spine Biologics 151
  • Table of Contents
  • 1 Industry Overview 1
  • 1.1 Definition and Specifications of Spine Biologics 1
  • 1.1.1 Definition of Spine Biologics 1
  • 1.1.2 Specifications of Spine Biologics 2
  • 1.2 Classification of Spine Biologics 3
  • 1.2.1 Bone Graft 4
  • 1.2.2 Bone Graft Substitute 4
  • 1.2.3 Platelet Rich Plasma 5
  • 1.2.4 BMAC 5
  • 1.3 Applications of Spine Biologics 6
  • 1.3.1 Anterior Cervical Discectomy and Fusion 7
  • 1.3.2 Posterior Lumbar Interbody Fusion 7
  • 1.4 Industry Chain Structure of Spine Biologics 8
  • 1.5 Industry Overview and Major Regions Status of Spine Biologics 8
  • 1.5.1 Industry Overview of Spine Biologics 8
  • 1.5.2 Global Major Regions Status of Spine Biologics 9
  • 1.6 Industry Policy Analysis of Spine Biologics 10
  • 1.7 Industry News Analysis of Spine Biologics 12
  • 2 Manufacturing Cost Structure Analysis of Spine Biologics 15
  • 2.1 Raw Material Suppliers Analysis of Spine Biologics 15
  • 2.2 Equipment Suppliers Analysis of Spine Biologics 16
  • 2.3 Labor Cost Analysis of Spine Biologics 16
  • 2.4 Other Costs Analysis of Spine Biologics 19
  • 2.5 Manufacturing Cost Structure Analysis of Spine Biologics 20
  • 2.6 Manufacturing Process Analysis of Spine Biologics 21
  • 3 Technical Data and Manufacturing Plants Analysis 22
  • 3.1 Capacity of Global Key Manufacturers in 2015 22
  • 3.2 Key Manufacturing Plants Distribution of Global Key Spine Biologics Manufacturers in 2015 22
  • 3.3 R&D Status and Technology Source of Global Spine Biologics Key Manufacturers in 2015 23
  • 4 Capacity, Production and Revenue Analysis of Spine Biologics by Regions, Types and Manufacturers 24
  • 4.1 Global Capacity, Production and Revenue of Spine Biologics by Regions 2011-2016 24
  • 4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Spine Biologics 2011-2016 27
  • 4.3 Global Production and Revenue of Spine Biologics by Types 2011-2016 33
  • 4.4 Global Capacity, Production and Revenue of Spine Biologics by Manufacturers 2011-2016 36
  • 5 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Regions, Types and Manufacturers 43
  • 5.1 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Regions 2011-2016 43
  • 5.2 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Types 2011-2016 46
  • 5.3 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Manufacturers 2011-2016 49
  • 6 Consumption Volume, Consumption Value and Sale Price Analysis of Spine Biologics by Regions, Types and Applications 54
  • 6.1 Global Consumption Volume and Consumption Value of Spine Biologics by Regions 2011-2016 54
  • 6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Spine Biologics 2011-2016 57
  • 6.3 Global Consumption Volume and Consumption Value of Spine Biologics by Types 2011-2016 62
  • 6.4 Global Consumption Volume and Consumption Value of Spine Biologics by Applications 2011-2016 65
  • 6.5 Sale Price of Spine Biologics by Regions 2011-2016 68
  • 6.6 Sale Price of Spine Biologics by Types 2011-2016 68
  • 6.7 Sale Price of Spine Biologics by Applications 2011-2016 69
  • 7 Supply, Import, Export and Consumption Analysis of Spine Biologics 70
  • 7.1 Supply, Consumption and Gap of Spine Biologics 2011-2016 70
  • 7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 71
  • 7.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 72
  • 7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 73
  • 7.5 Asia Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 74
  • 8 Analysis of Spine Biologics Industry Key Manufacturers 75
  • 8.1 Medtronic 75
  • 8.1.1 Company Profile 75
  • 8.1.2 Product Information 76
  • 8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 76
  • 8.2 Depuy Synthes 78
  • 8.2.1 Company Profile 78
  • 8.2.2 Product Information 79
  • 8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 80
  • 8.3 Stryker Corporation 81
  • 8.3.1 Company Profile 81
  • 8.3.2 Product Information 82
  • 8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 83
  • 8.4 Nuvasive 84
  • 8.4.1 Company Profile 84
  • 8.4.2 Product Information 85
  • 8.4.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 86
  • 8.5 Zimmer Biomet 87
  • 8.5.1 Company Profile 87
  • 8.5.2 Product Information 88
  • 8.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 89
  • 8.6 Orthofix International 90
  • 8.6.1 Company Profile 90
  • 8.6.2 Product Information 91
  • 8.6.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 91
  • 8.7 Globus Medical 93
  • 8.7.1 Company Profile 93
  • 8.7.2 Product Information 94
  • 8.7.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 94
  • 8.8 Alphatec spine 96
  • 8.8.1 Company Profile 96
  • 8.8.2 Product Information 97
  • 8.8.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 97
  • 8.9 K2M 99
  • 8.9.1 Company Profile 99
  • 8.9.2 Product Information 100
  • 8.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 100
  • 8.10 Exactech 102
  • 8.10.1 Company Profile 102
  • 8.10.2 Product Information 103
  • 8.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 103
  • 8.11 Wright Medical Technology 105
  • 8.11.1 Company Profile 105
  • 8.11.2 Product Information 106
  • 8.11.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 106
  • 8.12 X-Spine Systems 108
  • 8.12.1 Company Profile 108
  • 8.12.2 Product Information 109
  • 8.12.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 109
  • 8.13 Nutech 111
  • 8.13.1 Company Profile 111
  • 8.13.2 Product Information 112
  • 8.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 112
  • 8.14 Arthrex 114
  • 8.14.1 Company Profile 114
  • 8.14.2 Product Information 115
  • 8.14.3 Capacity, Production, Price, Cost, Gross, and Revenue 115
  • 9 Marketing Trader or Distributor Analysis of Spine Biologics 117
  • 9.1 Marketing Channels Status of Spine Biologics 117
  • 9.2 Traders or Distributors with Contact Information of Spine Biologics 118
  • 9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Spine Biologics 119
  • 9.4 Regional Import, Export and Trade Analysis of Spine Biologics 119
  • 11 Development Trend of Analysis of Spine Biologics 121
  • 11.1 Capacity, Production and Revenue Forecast of Spine Biologics by Regions and Types 121
  • 11.1.1 Global Capacity, Production and Revenue of Spine Biologics by Regions 2016-2021 121
  • 11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Spine Biologics 2016-2021 124
  • 11.1.3 Global Capacity, Production and Revenue of Spine Biologics by Types 2016-2021 129
  • 11.2 Consumption Volume and Consumption Value Forecast of Spine Biologics by Regions, Types and Applications 132
  • 11.2.1 Global Consumption Volume and Consumption Value of Spine Biologics by Regions 2016-2021 132
  • 11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Spine Biologics 2016-2021 135
  • 11.2.3 Global Consumption Volume and Consumption Value of Spine Biologics by Types 2016-2021 140
  • 11.2.4 Global Consumption Volume and Consumption Value of Spine Biologics by Applications 2016-2021 143
  • 11.3 Supply, Import, Export and Consumption Forecast of Spine Biologics 146
  • 11.3.1 Supply, Consumption and Gap of Spine Biologics 2016-2021 146
  • 11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 147
  • 11.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 148
  • 11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 148
  • 11.3.5 Asia Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 149
  • 12 New Project Investment Feasibility Analysis of Spine Biologics 150
  • 12.1 New Project SWOT Analysis of Spine Biologics 150
  • 12.2 New Project Investment Feasibility Analysis of Spine Biologics 150
  • 12.2.1 Project Name 150
  • 12.2.2 Investment Budget 150
  • 12.2.3 Project Product Solutions 151
  • 13 Conclusion of the Global Spine Biologics Industry 2016 Market Research Report 152

Please select a license type

Share

Related Products

QYResearchGlobal Spine Biologics Industry 2016 Market Research ReportProduct ThumbnailGlobal Spine Biologics Industry 2016 Market Research Report, Industry Report available for $2800Product #: 508111
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved